Drug Exposure Registry for Long-Term Follow-Up of Subjects Exposed to GSK2248761

Trial Profile

Drug Exposure Registry for Long-Term Follow-Up of Subjects Exposed to GSK2248761

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Fosdevirine (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors ViiV Healthcare
  • Most Recent Events

    • 06 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 26 Jun 2014 Planned End Date changed from 1 Jul 2015 to 1 Jan 2015 as reported by ClinicalTrials.gov record.
    • 26 Jun 2014 Planned primary completion date changed from 1 Jul 2015 to 1 Jan 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top